Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CCR
    (1)
  • JAK
    (2)
  • STAT
    (1)
  • Others
    (7)
Filter
Search Result
Results for "

jak-in-5

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Activity
  • Compound Libraries
    2
    TargetMol | inventory
  • Recombinant Protein
    2
    TargetMol | natural
JAK-IN-5
T117102096999-92-5In house
JAK-IN-5 is a JAK inhibitor.
  • $197
In Stock
Size
QTY
JAK-IN-5 hydrochloride
T11710L2751323-21-2In house
JAK-IN-5 hydrochloride is a JAK inhibitor [1].
  • $1,620
1-2 weeks
Size
QTY
W1131 TFA
T80847
W1131 TFA is a potent STAT3 inhibitor inducing ferroptosis and effectively halting cancer progression in subcutaneous xenograft, organoid, and PDX models of gastric cancer. It mitigates chemoresistance to 5-FU in cancer cells and modulates the cell cycle, DNA damage response, and oxidative phosphorylation, targeting pathways such as IL6-JAK-STAT3 and ferroptosis [1].
  • Inquiry Price
Size
QTY
W1131
T735582740522-79-4
W1131, a potent STAT3 inhibitor, effectively triggers ferroptosis and suppresses cancer progression across various models including gastric cancer cell subcutaneous xenograft, organoids, and patient-derived xenograft (PDX). Additionally, W1131 overcomes chemical resistance in cancer cells to 5-FU by regulating cell cycle, DNA damage response, and oxidative phosphorylation pathways, notably the IL6-JAK-STAT3 and ferroptosis pathways [1].
  • $985
6-8 weeks
Size
QTY
JAK-IN-14
T97641973485-06-1
JAK-IN-14 is a potent and selective JAK1 inhibitor with an IC50 of <5 μM, exhibiting over 8-fold selectivity for JAK1 compared to JAK2 and JAK3 [1].
  • $1,570
6-8 weeks
Size
QTY
SYK/JAK-IN-1
T630862737326-28-0
SYK/JAK-IN-1 is a dual SYK/JAK inhibitor with IC50 values of less than 5 nM for both SYK and JAK2.
  • $2,140
6-8 weeks
Size
QTY
HAT-SIL-TG-1&AT
T74800
HAT-SIL-TG-1&AT, a hypoxia-activated prodrug, functions as a Janus tyrosine kinase (JAK) inhibitor demonstrating antitumor effects by inhibiting JAK-STAT signaling within tumor tissues. It also suppresses the proliferation of HEL cells and downregulates phosphorylated STAT3/5 in hypoxic conditions.
  • Inquiry Price
Size
QTY
JAK-IN-20
T635811654776-91-6
JAK-IN-20 is a potent, orally active, broad-based JAK inhibitor, effective on JAK1 (IC50: 7 nM), JAK2 (IC50: 5 nM), and JAK3 (IC50: 14 nM), exhibiting excellent pharmacokinetic and anti-inflammatory activity in vivo.
  • $1,520
6-8 weeks
Size
QTY
5-epi-Arvestonate A
T755352767066-84-0
5-epi-Arvestonate A, a sesquiterpenoid extracted from Seriphidium transiliense whole plants, enhances melanogenic production by stimulating MITF and tyrosinase family gene transcription. Additionally, it suppresses IFN-γ-chemokine expression via the JAK/STAT signaling pathway in HaCaT cells [1].
  • Inquiry Price
Size
QTY
JAK-IN-3
T117041400876-94-9
JAK-IN-3 is a potent JAK inhibitor, with IC50 values of 3 nM, 5 nM, 34 nM and 70 nM for JAK3, JAK1, TYK2 and JAK2, respectively.
  • $1,820
8-10 weeks
Size
QTY